KATELYN BECHT: Open Payments
NPI 1881028165 · CARMEL, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$748 in 40 payments from 17 companies in 2025. Trend: 2023 $17 · 2024 $240 · 2025 $748
Food & beverage: $748
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $163 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| PFIZER INC. | 3 | $52 |
| ABBVIE INC. | 2 | $52 |
| Amgen Inc. | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Exact Sciences Corporation | 2 | $39 |
| Corium, LLC | 2 | $33 |
| Dynavax Technologies Corporation | 2 | $33 |
Products named: REXULTI, Ozempic, QULIPTA, GEMTESA, PREVNAR 20, Wegovy, AIRSUPRA, Azstarys.
Industry payments across IN — which companies pay providers there.
